IDiyas

For the Inventor, By the Inventor

Ludwigshafen, Germany

Margaretha Henrica Maria Bakker

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Ludwigshafen, DE (2012 - 2018)
  • Seeheim-Jugenheim, DE (2014 - 2018)

Company Filing History:

goldMedal12 out of 150 
 
Abb Vie Deutschland Gmbh & Co. Kg
 patents
silverMedal3 out of 139 
 
Abbott Gmbh & Co Kg
 patents
bronzeMedal3 out of 822 
 
Abbvie Inc.
 patents
4. 1 out of 17 
 
Abbvie Deutschland Gmbh and Co Kg
 patents
where one patent can have more than one assignee

Years Active: 2012-2018

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 10118926 - Tricyclic quinoline and quinoxaline derivatives (2018-11-06),
2. 10100048 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2018-10-16),
3. 9994568 - Tricyclic quinoline and quinoxaline derivatives (2018-06-12),
4. 9856234 - Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors (2018-01-02),
5. 9573950 - Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators (2017-02-21),
6. 9540376 - Hexahydrodiazepinoquinolines carrying a substituted alkyl radical (2017-01-10),
7. 9540370 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2017-01-10),
8. 9266855 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2016-02-23),
9. 9242933 - Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor) (2016-01-26),
10. 9169253 - Tricyclic quinoline and quinoxaline derivatives (2015-10-27),
11. 9090592 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2015-07-28),
12. 8664214 - Small molecule potentiators of metabotropic glutamate receptors I (2014-03-04),
13. 8642598 - Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors (2014-02-04),
14. 8455648 - 1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3) (2013-06-04),
15. 8318793 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2012-11-27),

Title: **Margaretha Henrica Maria Bakker: A Pioneer in Pharmaceutical Innovation**

Introduction

Margaretha Henrica Maria Bakker is a distinguished inventor based in Ludwigshafen, Germany. With an impressive portfolio of 16 patents, she has made significant contributions to the field of pharmaceuticals. Her innovative work focuses on developing compounds that have important applications in treating various medical conditions.

Latest Patents

Among her latest innovations, Bakker has developed patents for tricyclic quinoline and quinoxaline derivatives. This particular invention pertains to pharmaceutical compositions that utilize these compounds as modulators of the 5-HT receptor. These modulators serve as agonists or partial agonists, providing potential benefits in the prevention and treatment of conditions responsive to 5-HT receptor modulation.

Another notable patent involves novel heterocyclic compounds that act as inhibitors for glycogen synthase kinase 3 (GSK-3). This invention encompasses methods for synthesizing these compounds, as well as their application in medical treatments.

Career Highlights

Bakker has worked with leading companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and Abbott GmbH & Co. KG. Her efforts in research and development have considerably advanced the understanding and effectiveness of pharmacological therapies.

Collaborations

Throughout her career, Bakker has collaborated with esteemed professionals in her field, including Sean Colm Turner and Wilfried Martin Braje. These partnerships have fostered a collaborative environment that has been essential to her innovative work.

Conclusion

Margaretha Henrica Maria Bakker's expertise and dedication to pharmaceutical innovation are evident in her significant contributions through her patents. Her work not only enhances our understanding of medicinal compounds but also paves the way for new treatment options in healthcare. As she continues to lead in her field, her influential role marks her as a notable inventor in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…